Tīmeklis2024. gada 6. jūl. · WATERTOWN, Mass., July 06, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein degradation to deliver novel small molecule protein degrader medicines, today announced the closing of its upsized underwritten public … Tīmeklis2024. gada 19. aug. · The Pre-Funded Warrants will have an exercise price of $0.0001 per share of Common Stock, be immediately exercisable and remain exercisable until exercised in full. Kymera anticipates the gross proceeds from the PIPE to be approximately $150.0 million, before deducting offering expenses. The financing is …
Kymera Therapeutics Appoints Elena Ridloff, CFA, to Board of ... - Yahoo!
TīmeklisSee the company profile for Kymera Therapeutics, Inc. (KYMR) including business summary, industry/sector information, number of employees, business summary, … Tīmeklis2024. gada 1. jūl. · WATERTOWN, Mass., June 30, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein degradation to deliver novel small molecule protein degrader medicines, today announced the pricing of its upsized underwritten public … homes for sale in daviess county
Kymera Therapeutics to Report First Quarter 2024 ... - Yahoo Finance
Tīmeklis2024. gada 9. apr. · All of the below ideas for biotech stocks to buy should be considered speculative. However, they also have potential catalysts that can see them produce 100% returns. XNCR. Xencor. $28.86. Tīmeklis2024. gada 19. apr. · WATERTOWN, Mass., April 19, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical … TīmeklisFind out the direct holders, institutional holders and mutual fund holders for Kymera Therapeutics, Inc. (KYMR). homes for sale in daviess county indiana